Skip to main content

Table 1 Characteristics of the patients investigated

From: Early prediction of therapy response in patients with acute myeloid leukemia by nucleosomal DNA fragments

  Median Range
Age (y) 62 22 – 76
  Number Percentage
Gender
Female 12 (48.0)
Male 13 (52.0)
Histology
M1 6 (24.0)
M2 8 (32.0)
M3 1 (4.0)
M4 5 (20.0)
M6 3 (12.0)
Unknown 2 (8.0)
Cytogenetics
Normal 13 (12.0)
Trisomy 8 1 (4.0)
Trisomy 11 1 (4.0)
Trisomy 21, Isochrom X 1 (4.0)
Mosaic 46XX, 45X0 1 (4.0)
Inversion 16 2 (4.0)
Inversion 3 1 (4.0)
Inversion 3, Monosomy 7 1 (4.0)
Pericentric Inversion 4 1 (4.0)
Translocation (2;5) 1 (4.0)
Translocation (8;21) 1 (4.0)
Translocation (15;17) 1 (4.0)
Immunophenotype
MPO, CD13, CD33 15 (60.0)
MPO, CD13, CD33, CD 14 1 (4.0)
MPO, CD13, CD33, CD3, CD7, Cd2, TdT 1 (4.0)
Not available 8 (32.0)
Mode of therapy
TAD 9 (36.0)
HAM 5 (20.0)
TAD/HAM 7 (28.0)
HAM/HAM 2 (8.0)
Relapse therapy 2 (8.0)
Therapy response
Complete remission 18 (72.0)
Non-Responders 7 (28.0)